The ROE (Return on Equity) of Ryvu Therapeutics SA (RVU.WA) is -77.45%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2024-12-31 | -77.45% |
| 2023-12-31 | -35.48% |
| 2022-12-31 | -24.40% |
| 2021-12-31 | -49.02% |
| 2020-12-31 | -14.16% |
| 2019-12-31 | 236.89% |
| 2018-12-31 | -0.06% |
| 2017-12-31 | 10.28% |
| 2016-12-31 | 4.91% |
| 2015-12-31 | 13.50% |